|
| | Publication Year | Title | Author(s) |
| 1 | 1-Dec-1994 | Blood loss and transfusion requirements in liver transplantation: experience with the first 75 cases. | McNicol, P L; Liu, G; Harley, I D; McCall, Peter R ; Przybylowski, G M; Bowkett, J; Angus, Peter W ; Hardy, Kenneth John; Jones, Robert M |
| 2 | 10-Apr-2010 | Changes in the renin angiotensin system during the development of colorectal cancer liver metastases. | Neo, Jaclyn H; Ager, Eleanor I; Angus, Peter W ; Zhu, Jin; Herath, Chandana B; Christophi, Christopher |
| 3 | 8-Jul-1993 | Combination antiviral therapy controls severe post-liver transplant recurrence of hepatitis B virus infection. | Angus, Peter W ; Richards, Michael J; Bowden, S; Ireton, J; Sinclair, R; Jones, R ; Locarnini, S |
| 4 | 30-May-2012 | Early-onset versus late-onset nonanastomotic biliary strictures post liver transplantation: risk factors reflect different pathogenesis. | Howell, Jessica A; Gow, Paul J ; Angus, Peter W ; Jones, Robert M ; Wang, Bao-Zhong; Bailey, Michael J; Fink, Michael A |
| 5 | 1-Dec-2001 | Hepatocellular carcinoma and chemoembolization. | Harris, M; Gibbs, P; Cebon, Jonathan S ; Jones, R ; Sewell, Richard B; Schelleman, Tony; Angus, Peter W |
| 6 | 1-Sep-1993 | High-dose oral acyclovir reduces the incidence of cytomegalovirus infection in liver transplant recipients. | Mollison, L C; Richards, Michael J; Johnson, Paul D R ; Hayes, K; Munckhof, Wendy J; Jones, Robert M ; Dabkowski, P D; Angus, Peter W |
| 7 | 13-Sep-2013 | Identifying the superior measure of rapid fibrosis for predicting premature cirrhosis after liver transplantation for hepatitis C. | Howell, Jessica; Sawhney, R; Angus, Peter W ; Fink, M ; Jones, R ; Wang, B Z; Visvanathan, K; Crowley, Peter; Gow, Paul J |
| 8 | 1-Nov-2004 | Kidney failure associated with liver transplantation or liver failure: the impact of continuous veno-venous hemofiltration. | Naka, Toshio; Wan, Li; Bellomo, Rinaldo ; Wang, B; Jones, R ; Berry, R; Angus, Peter W ; Gow, Paul J |
| 9 | 1-Oct-1996 | Liver transplantation in metastatic carcinoid tumour. | Coperchini, M L; Jones, R ; Angus, Peter W ; Read, A; Schmidt, G; Zalcberg, John R |
| 10 | 1-Nov-1994 | Lymphoproliferative disease of donor origin arising in patients after orthotopic liver transplantation. | Armes, J E; Angus, Peter W ; Southey, M C; Battaglia, S E; Ross, B C; Jones, Robert M ; Venter, D J |
| 11 | 27-Apr-2014 | A novel biomarker of immune function and initial experience in a transplant population. | Sood, Siddharth ; Cundall, Diana; Yu, Lijia; Miyamasu, Misato; Boyle, Jefferey S; Ong, Sim Y; Gow, Paul J ; Jones, Robert M ; Angus, Peter W ; Visvanathan, Kumar; Testro, Adam G |
| 12 | 1-Apr-2005 | Predictors of improvement in renal function after calcineurin inhibitor withdrawal for post-liver transplant renal dysfunction. | Hong, Matthew Kh; Angus, Peter W ; Jones, Robert M ; Vaughan, Rhys B ; Gow, Paul J |
| 13 | 1-Oct-1992 | Prostaglandin E1 therapy in orthotopic liver transplantation recipients: indications and outcome. | Tancharoen, S; Jones, Robert M ; Angus, Peter W ; Michell, I D; McNicol, Larry; Hardy, Kenneth John |
